Abstract
Purpose
The purpose of this study was to compare the health-related quality of life (HRQOL) of Chinese patients with prostate cancer against the general population and patients with colorectal cancer, breast cancer, nasopharyngeal cancer, and leukemia.
Methods
Chinese male patients (n = 291) with a confirmed diagnosis of prostate cancer were recruited from a urological specialist outpatient clinic in Hong Kong. HRQOL was measured by a condition-specific Functional Assessment of Cancer Therapy-Prostate (FACT-P) and a generic Chinese (HK) SF-12 Health Survey Version 2 (SF-12v2) questionnaire. Mean HRQOL scores of condition-specific and generic questionnaires were compared to available scores derived from other cancers and age-matched male general population, respectively.
Results
Chinese patients with prostate cancer had lower general health and vitality domains and lower mental component summary scores than the age-matched Hong Kong normative population. Patients with prostate cancer reported better condition-specific HRQOL (physical well-being, emotional well-being and function well-being) when compared to general cancer population, patients with breast cancer, colorectal cancer, nasopharyngeal cancer, and leukemia in Hong Kong.
Conclusions
Patients with prostate cancer substantially perceived their HRQOL to be better, compared to patients with other cancers, with overall health, energy, and mental health below of Hong Kong general population. Interventions should target at these domains in order to improve the HRQOL of patients with prostate cancer. It is reassuring to find that prostate cancer had less negative impact on HRQOL than other cancer types did.
Similar content being viewed by others
References
Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International Journal of Cancer Journal International du Cancer 127(12):2893–2917. doi:10.1002/ijc.25516
Eton DT, Lepore SJ (2002) Prostate cancer and health-related quality of life: a review of the literature. Psycho-Oncology 11(4):307–326. doi:10.1002/pon.572
Bouchardy C, Fioretta G, Rapiti E, Verkooijen HM, Rapin CH, Schmidlin F, Miralbell R, Zanetti R (2008) Recent trends in prostate cancer mortality show a continuous decrease in several countries. International Journal of Cancer Journal International du Cancer 123(2):421–429. doi:10.1002/ijc.23520
Kronenwetter C, Weidner G, Pettengill E, Marlin R, Crutchfield L, McCormac P, Raisin CJ, Ornish D (2005) A qualitative analysis of interviews of men with early stage prostate cancer: the prostate cancer lifestyle trial. Cancer Nurs 28(2):99–107
Krupski TL, Fink A, Kwan L, Maliski S, Connor SE, Clerkin B, Litwin MS (2005) Health-related quality-of-life in low-income, uninsured men with prostate cancer. J Health Care Poor Underserved 16(2):375–390. doi:10.1353/hpu.2005.0037
Penson DF, Litwin MS, Aaronson NK (2003) Health related quality of life in men with prostate cancer. J Urol 169(5):1653–1661
Katz A (2007) Quality of life for men with prostate cancer. Cancer Nurs 30(4):302–308
Ishihara M, Suzuki H, Akakura K, Komiya A, Imamoto T, Tobe T, Ichikawa T (2006) Baseline health-related quality of life in the management of prostate cancer. International Journal of Urology : Official Journal of the Japanese Urological Association 13(7):920–925. doi:10.1111/j.1442-2042.2006.01441.x
Rosenfeld B, Roth AJ, Gandhi S, Penson D (2004) Differences in health-related quality of life of prostate cancer patients based on stage of cancer. Psycho-Oncology 13(11):800–807
Zenger M, Lehmann-Laue A, Stolzenburg JU, Schwalenberg T, Ried A, Hinz A (2010) The relationship of quality of life and distress in prostate cancer patients compared to the general population. Psycho-social medicine 7:Doc02. doi:10.3205/psm000064
Ashing-Giwa KT (2005) The contextual model of HRQoL: a paradigm for expanding the HRQoL framework. Qual Life Res 14(2):297–307
Choi EP, Lam CL, Chin WY (2014) The health-related quality of life of Chinese patients with lower urinary tract symptoms in primary care. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation 23(10):2723–2733. doi:10.1007/s11136-014-0725-5
Wong CKH, Choi EPH, Tsu JHL, Ho BSH, Ng ATL, Chin WY, Yiu MK (2015) Psychometric properties of functional assessment of cancer therapy-prostate (FACT-P) in Chinese patients with prostate cancer. Quality of Life Research 24(10):2397–2402. doi:10.1007/s11136-015-0993-8
Ware JE, Kosinski M, Keller SD (1995) SF-12: how to score the SF-12 physical and mental health summary scales. Health Institute, New England Medical Center
Lam ET, Lam CL, Fong DY, Huang WW (2013) Is the SF-12 version 2 health survey a valid and equivalent substitute for the SF-36 version 2 health survey for the Chinese? J Eval Clin Pract 19(1):200–208. doi:10.1111/j.1365-2753.2011.01800.x
Lam CL, Wong CH, Lam ET, Lo YY, Huang WW (2010) Population norm of Chinese (HK) SF-12 health survey-version 2 of Chinese adults in Hong Kong. Hong Kong Practitioner 32(2):77–86
Esper P, Mo F, Chodak G, Sinner M, Cella D, Pienta KJ (1997) Measuring quality of life in men with prostate cancer using the functional assessment of cancer therapy-prostate instrument. Urology 50(6):920–928. doi:10.1016/S0090-4295(97)00459-7
Patrick DL, Deyo RA (1989) Generic and disease-specific measures in assessing health status and quality of life. Medical care:S217-S232
Yu CL, Fielding R, Chan CL, Tse VK, Choi PH, Lau WH, Choy DT, SK O, Lee AW, Sham JS (2000) Measuring quality of life of Chinese cancer patients: a validation of the Chinese version of the Functional Assessment of Cancer Therapy-General (FACT-G) scale. Cancer 88(7):1715–1727
Yu CL, Fielding R, Chan CL (2003) The mediating role of optimism on post-radiation quality of life in nasopharyngeal carcinoma. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation 12(1):41–51
Wong WS, Fielding R (2007) Change in quality of life in Chinese women with breast cancer: changes in psychological distress as a predictor. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer 15(11):1223–1230. doi:10.1007/s00520-006-0190-y
Wong CK, Lam CL, Law WL, Poon JT, Kwong DL, Tsang J, Wan YF (2013) Condition-specific measure was more responsive than generic measure in colorectal cancer: all but social domains. J Clin Epidemiol 66(5):557–565. doi:10.1016/j.jclinepi.2012.11.010
Lau AK, Chang CH, Tai JW, Eremenco S, Liang R, Lie AK, Fong DY, Lau CM (2002) Translation and validation of the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) Version 4 quality of life instrument into traditional Chinese. Bone Marrow Transplant 29(1):41–49. doi:10.1038/sj.bmt.1703313
Wong CK, Lam CL, Poon JT, Kwong DL (2013) Clinical correlates of health preference and generic health-related quality of life in patients with colorectal neoplasms. PLoS One 8(3):e58341. doi:10.1371/journal.pone.0058341
Sloan JA, Cella D, Hays RD (2005) Clinical significance of patient-reported questionnaire data: another step toward consensus. J Clin Epidemiol 58(12):1217–1219. doi:10.1016/j.jclinepi.2005.07.009
Thomas JC, Hersen M (2011) Understanding research in clinical and counseling psychology. Taylor & Francis
Bloch S, Love A, Macvean M, Duchesne G, Couper J, Kissane D (2007) Psychological adjustment of men with prostate cancer: a review of the literature. BioPsychoSocial Medicine 1:2. doi:10.1186/1751-0759-1-2
Kunkel EJ, Bakker JR, Myers RE, Oyesanmi O, Gomella LG (2000) Biopsychosocial aspects of prostate cancer. Psychosomatics 41(2):85–94. doi:10.1176/appi.psy.41.2.85
Watts S, Leydon G, Birch B, Prescott P, Lai L, Eardley S, Lewith G (2014) Depression and anxiety in prostate cancer: a systematic review and meta-analysis of prevalence rates. BMJ Open 4(3):e003901. doi:10.1136/bmjopen-2013-003901
Dale W, Bilir P, Han M, Meltzer D (2005) The role of anxiety in prostate carcinoma: a structured review of the literature. Cancer 104(3):467–478. doi:10.1002/cncr.21198
Korfage IJ, Essink-Bot ML, Janssens AC, Schroder FH, de Koning HJ (2006) Anxiety and depression after prostate cancer diagnosis and treatment: 5-year follow-up. Br J Cancer 94(8):1093–1098. doi:10.1038/sj.bjc.6603057
Basaria S, Lieb 2nd J, Tang AM, DeWeese T, Carducci M, Eisenberger M, Dobs AS (2002) Long-term effects of androgen deprivation therapy in prostate cancer patients. Clin Endocrinol 56(6):779–786
Alibhai SM, Gogov S, Allibhai Z (2006) Long-term side effects of androgen deprivation therapy in men with non-metastatic prostate cancer: a systematic literature review. Crit Rev Oncol Hematol 60(3):201–215. doi:10.1016/j.critrevonc.2006.06.006
Leung PC (2010) Healthy aging. World Scientific Publishing Company, Singapore
Lahans T (2007) Integrating conventional and Chinese medicine in cancer care: a clinical guide. Churchill Livingstone, Edinburgh
Bjorner JB, Wallenstein GV, Martin MC, Lin P, Blaisdell-Gross B, Tak Piech C, Mody SH (2007) Interpreting score differences in the SF-36 vitality scale: using clinical conditions and functional outcomes to define the minimally important difference. Curr Med Res Opin 23(4):731–739. doi:10.1185/030079907X178757
Sprangers MA, Schwartz CE (1999) Integrating response shift into health-related quality of life research: a theoretical model. Soc Sci Med 48(11):1507–1515
Efficace F, Kemmler G, Vignetti M, Mandelli F, Molica S, Holzner B (2008) Health-related quality of life assessment and reported outcomes in leukaemia randomised controlled trials—a systematic review to evaluate the added value in supporting clinical decision making. Eur J Cancer 44(11):1497–1506. doi:10.1016/j.ejca.2008.03.017
Bellm LA, Epstein JB, Rose-Ped A, Martin P, Fuchs HJ (2000) Patient reports of complications of bone marrow transplantation. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer 8(1):33–39
Litwin MS, Hays RD, Fink A, Ganz PA, Leake B, Leach GE, Brook RH (1995) Quality-of-life outcomes in men treated for localized prostate cancer. Jama 273(2):129–135
Brandeis JM, Litwin MS, Burnison CM, Reiter RE (2000) Quality of life outcomes after brachytherapy for early stage prostate cancer. J Urol 163(3):851–857
Wei JT, Dunn RL, Sandler HM, McLaughlin PW, Montie JE, Litwin MS, Nyquist L, Sanda MG (2002) Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer. J Clin Oncol 20(2):557–566
Choi E, Lam C, Chin W-Y (2014) Validation of the International Prostate Symptom Score in Chinese males and females with lower urinary tract symptoms. Health Qual Life Outcomes 12(1):1
Cella D, Nichol MB, Eton D, Nelson JB, Mulani P (2009) Estimating clinically meaningful changes for the functional assessment of cancer therapy—prostate: results from a clinical trial of patients with metastatic hormone-refractory prostate cancer. Value Health 12(1):124–129
Eton DT, Lepore SJ (2002) Prostate cancer and health-related quality of life: a review of the literature†. Psycho-Oncology 11(4):307
Segal RJ, Reid RD, Courneya KS, Malone SC, Parliament MB, Scott CG, Venner PM, Quinney HA, Jones LW, D’Angelo ME, Wells GA (2003) Resistance exercise in men receiving androgen deprivation therapy for prostate cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 21(9):1653–1659. doi:10.1200/JCO.2003.09.534
Knols R, Aaronson NK, Uebelhart D, Fransen J, Aufdemkampe G (2005) Physical exercise in cancer patients during and after medical treatment: a systematic review of randomized and controlled clinical trials. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 23(16):3830–3842. doi:10.1200/JCO.2005.02.148
Knight SJ, Chmiel JS, Kuzel T, Sharp L, Albers M, Fine R, Moran EM, Nadler RB, Sharifi R, Bennett CL (1998) Quality of life in metastatic prostate cancer among men of lower socioeconomic status: feasibility and criterion related validity of 3 measures. J Urol 160(5):1765–1769
Kim SP, Knight SJ, Tomori C, Colella KM, Schoor RA, Shih L, Kuzel TM, Nadler RB, Bennett CL (2001) Health literacy and shared decision making for prostate cancer patients with low socioeconomic status. Cancer Investig 19(7):684–691
Acknowledgments
The authors wish to express their gratitude to Professor Cindy L.K. Lam for the design and planning of this study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests.
Rights and permissions
About this article
Cite this article
Choi, E.P.H., Wong, C.K.H., Tsu, J.H.L. et al. Health-related quality of life of Chinese patients with prostate cancer in comparison to general population and other cancer populations. Support Care Cancer 24, 1849–1856 (2016). https://doi.org/10.1007/s00520-015-2980-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-015-2980-6